S Saglam
Overview
Explore the profile of S Saglam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Demir S, Olgac M, Saglam S, Gelincik A, Colakoglu B, Buyukozturk S
J Investig Allergol Clin Immunol
. 2016 Mar;
26(1):66-7.
PMID: 27012024
No abstract available.
2.
Erdogdu Y, Saglam S, Gulluoglu M
Spectrochim Acta A Mol Biomol Spectrosc
. 2015 Mar;
146:88-96.
PMID: 25813166
Fourier-Transform-Infrared, Fourier-Transform-Raman and Nuclear Magnetic Rezonans spectra of 1-(p-tolylsulfonyl) pyrrole molecule have been recorded. In the powder form, vibrational spectra of 1-(p-tolylsulfonyl) pyrrol molecule were investigated in the region 4000-400...
3.
Saglam S, Disli A, Erdogdu Y, Marchewka M, Kanagathara N, Bay B, et al.
Spectrochim Acta A Mol Biomol Spectrosc
. 2014 Aug;
135:1011-8.
PMID: 25171051
In this study, 5-(benzylthio)-1-cylopentyl-1H-tetrazole (5B1C1HT) have been synthesized. Boiling points of the obtained compound have been determined and it has been characterized by FT-IR, (1)H NMR, (13)C-APT and LC-MS spectroscopy...
4.
Keskin S, Yildiz I, Sen F, Aydogan F, Kilic L, Ekenel M, et al.
Clin Transl Oncol
. 2012 Oct;
15(5):403-8.
PMID: 23054756
Purpose: The aim of this retrospective study (from January 2007 to December 2011) was to investigate the efficacy and tolerability of mDCF schedule for chemotherapy-naïve AGC patients. Patients: Patients (n...
5.
Bitisik O, Saip P, Saglam S, Derin D, Dalay N
Genet Mol Res
. 2010 Jan;
9(1):97-106.
PMID: 20092039
Detection of residual tumor cells in the circulation can provide prognostic as well as therapeutic information and help in identifying patients at high risk for developing metastases. Maspin and mammaglobin...
6.
Topuz E, Derin D, Can G, Kurklu E, Cinar S, Aykan F, et al.
Invest New Drugs
. 2008 Sep;
26(6):567-72.
PMID: 18762864
In order to investigate the effect of kefir consumption on mucositis induced by 5-FU based chemotherapy (CT), we monitored the systemic immune response by measurement of the serum proinflammatory cytokine...
7.
Sakar B, Gumus M, Basaran M, Argon A, Ustuner Z, Ustaoglu M, et al.
Oncology
. 2008 May;
73(5-6):298-304.
PMID: 18477855
Background: Capecitabine has demonstrated high efficacy as first-line treatment for metastatic colorectal cancer (mCRC). In this non-randomized pilot study, we investigated the efficacy and safety of sequentially administered XELOX and...
8.
Turgut M, Akalan N, Saglam S
J Neurosurg Sci
. 1998 Oct;
42(1):61-3.
PMID: 9766276
Although chronic subdural hematomas (SDHs) are bilateral in about 20% of the cases, an acute SDH in one side associated with chronic SDH in "contralateral" side is an extremely rare...
9.
Varan A, Caner H, Saglam S, Buyukpamukcu M
Pediatr Radiol
. 1998 May;
28(5):311.
PMID: 9569267
No abstract available.
10.
Turgut M, Palaoglu S, Akpinar G, Saglam S
S Afr J Surg
. 1997 Aug;
35(3):131-3.
PMID: 9429330
A 24-year-old woman presented with left-sided ptosis, diplopia, sensory impairment on the left side of her face and diminished hearing in her left ear. The neurological findings were hypo-anesthesia in...